An investigation on behalf of investors of Mindray Medical International Ltd (ADR) (NYSE: MR) concerning possible violations of Federal Securities Laws by Mindray Medical International Ltd or others was announced.

The investigation by a law firm focuses on whether a series of statements made between January 11, 2010 and August 9, 2010, inclusive, regarding Mindray Medical Intl's business, its prospects and its operations were materially false and misleading at the time they were made.

Mindray Medical Intls annual Revenue increased from $344.33million in 07 to $704.31million in 2010. Its Net Income rose over the same time frame from $$91.31million in 2007 to $155.47million in 2010. For the first quarter in 2011 Mindray Medical International Ltd reported $180.90million quarterly Revenue compared to $145.84million one year earlier and a quarterly Net Income of $37.71million in 2011 compared to $36.20million for the first quarter in 2010.
Specifically, the investigation focuses on, among other thing, whether Mindray Medical International Ltd knew but failed to adequately disclose that it was experiencing declining sales domestically. The investigation also seeks to determine whether Mindray Medical International Ltd understated the level of competition it faced in penetrating the market for larger hospital systems in China.

Shares of Mindray Medical International Ltd (ADR) (Public, NYSE:MR) rose from as low as $14.80 per share in November 08 to as high as $38.82 in August 2010. However NYSE MR ADRs fell until the end of 2010 to $26.40 per share and despite a recent increase above $30 per share in May MR ADRs traded at under $28 per share in early 2011.